The level of serum CEA expression and the trend of its changes in the treatment process have been validated by several studies on the clinical value of assessing the efficacy and prognosis of NSCLC (Ardizzoni et al., 2006; Arrieta et al., 2013). Here, CEACAM5 is linked to non-small cell lung carcinoma.